FOI_25-197 MBBS Medicine admissions

Date of response: 11 July 2025

We have now considered your request of 22 June 2025 for the following information:

Can you please kindly provide information on the following for 2022,2023,2024,2025 for undergraduate entry medicine (A100):

Question 1. Total number of applicants received

Our response:

2022202320242025
212620891396S.43(2) Prejudice to commercial interests

Question 2. Total number of interviews sent

Our response:

2022202320242025
693703707S.43(2) Prejudice to commercial interests

Question 3. Total number of offers given

Our response:

2022202320242025
413479563S.43(2) Prejudice to commercial interests

Question 4. Total number of place on the course

Our response:

2022202320242025
203208208208

Question 5. Lowest and average UCAT score accepted for interview

Our response:

2022202320242025
Lowest UCAT 189023402190S.43(2) Prejudice to commercial interests
Average UCAT 273028392790S.43(2) Prejudice to commercial interests

Question 6. UCAT cut off score

Our response:

On this occasion it is not possible to provide any of the requested information. In line with your rights under section 1(1)(a) of the Act to be informed whether information is held, we confirm that the University does not hold any recorded information for the UCAT cut off score. There is no cut-off for UCAT for the MBBS Medicine course.

Question 7. Average and lowest SJT band achieved by interview holders

Our response:

2022202320242025
Lowest434S.43(2) Prejudice to commercial interests
Average 222S.43(2) Prejudice to commercial interests

Unfortunately, on this occasion, it is not possible to provide all the requested information. The Act contains a number of exemptions that allow public authorities to withhold certain information from release. We have applied the following exemption for the requested information relating to all medicine applicants for 2025 entry.

ExemptionReason
S.43(2) Prejudice to commercial interests Disclosure of information would be likely to prejudice the commercial interests of a person as defined by the Act.

We have applied this exemption for the requested information relating to the medicine applicant cycle 2025 entry. The University is currently in a live recruitment cycle for its medicine course, and it is our belief that release of this information would be likely to prejudice the commercial interests of the University of East Anglia.

Student recruitment is undoubtedly a commercial activity for all universities. The University’s success in recruiting students to the medicine course directly affects both our reputation and financial position.

To compete in the Higher Education market, with leading UK and international universities, the University must ensure that information that would be strategically useful to its competitors is not placed in the public domain. Release of such information would potentially compromise the University’s ability to attract and retain the high-quality students that allow it to be a progressive and sustainable institution.

The UK Higher Education sector is a highly competitive environment. All universities seek to recruit the best students from a limited pool of prospective UK and international applicants, as well as competing to attract high quality staff, research funding and accreditation. This competition is both on a national and international scale, with UK-based institutions in direct competition with institutions around the world for funding, students and staff.

The medicine course is expected to be an extremely popular course, and it is clear that real-time information relating to the information requested within this live recruitment cycle would be of interest to our competitors. It therefore follows that information during a live recruitment cycle for the medicine course can readily be seen as commercially sensitive.

We do not share information pertaining to live recruitment cycles with any of our competitors; this information would provide them with the insight to match and potentially exceed our recruitment activities. The University believes that its position would be severely compromised if it were to release information that would benefit its competitors.

We consider it would be likely for such prejudice to our interests to occur, given the sensitivity of the requested information, the consistent treatment of it as commercially sensitive by both this University and other Higher Education institutions, and the degree to which the number and value of applicants and subsequent registrants is now critical to any university’s success.

The application of this exemption requires an examination of the public interest in disclosure as opposed to that in non-disclosure.

The factors in favour of disclosure would include:

• There is a legitimate public interest in the information you have requested relating to the medicine course, both to further the transparency and accountability of public authority activities.

Factors in favour of withholding the information are largely laid out in the explanation for the use of the exemption above but would include:

• A public interest in protecting the ability of institutions to compete on a level playing field and to ensure that there is fair competition between universities for prospective students. By protecting the University’s real time recruitment information from public disclosure, we are acting in line with established practices across the sector within the UK and internationally in maintaining this fair competition.

• To disclose the requested information, at this stage in the process, would be likely to prejudice this institution’s competitive and commercial position, and it is difficult to see how this could be in the public interest.

After consideration of the above factors, we believe, on balance, that the public interest lies in withholding the requested information.

FOI_25-197 MBBS Medicine applicant data